Papers
Topics
Authors
Recent
Gemini 2.5 Flash
Gemini 2.5 Flash
102 tokens/sec
GPT-4o
59 tokens/sec
Gemini 2.5 Pro Pro
43 tokens/sec
o3 Pro
6 tokens/sec
GPT-4.1 Pro
50 tokens/sec
DeepSeek R1 via Azure Pro
28 tokens/sec
2000 character limit reached

Brain Latent Progression: Individual-based Spatiotemporal Disease Progression on 3D Brain MRIs via Latent Diffusion (2502.08560v1)

Published 12 Feb 2025 in cs.CV and cs.AI

Abstract: The growing availability of longitudinal Magnetic Resonance Imaging (MRI) datasets has facilitated AI-driven modeling of disease progression, making it possible to predict future medical scans for individual patients. However, despite significant advancements in AI, current methods continue to face challenges including achieving patient-specific individualization, ensuring spatiotemporal consistency, efficiently utilizing longitudinal data, and managing the substantial memory demands of 3D scans. To address these challenges, we propose Brain Latent Progression (BrLP), a novel spatiotemporal model designed to predict individual-level disease progression in 3D brain MRIs. The key contributions in BrLP are fourfold: (i) it operates in a small latent space, mitigating the computational challenges posed by high-dimensional imaging data; (ii) it explicitly integrates subject metadata to enhance the individualization of predictions; (iii) it incorporates prior knowledge of disease dynamics through an auxiliary model, facilitating the integration of longitudinal data; and (iv) it introduces the Latent Average Stabilization (LAS) algorithm, which (a) enforces spatiotemporal consistency in the predicted progression at inference time and (b) allows us to derive a measure of the uncertainty for the prediction. We train and evaluate BrLP on 11,730 T1-weighted (T1w) brain MRIs from 2,805 subjects and validate its generalizability on an external test set comprising 2,257 MRIs from 962 subjects. Our experiments compare BrLP-generated MRI scans with real follow-up MRIs, demonstrating state-of-the-art accuracy compared to existing methods. The code is publicly available at: https://github.com/LemuelPuglisi/BrLP.

Brain Latent Progression: Advancing Spatiotemporal Modeling of Disease Through Latent Diffusion

The paper "Brain Latent Progression: Individual-based Spatiotemporal Disease Progression on 3D Brain MRIs via Latent Diffusion" presents a methodological advancement in the field of neurological imaging, specifically addressing the challenges in modeling individual disease progression for neurodegenerative conditions using high-dimensional brain MRI data. This paper introduces Brain Latent Progression (BrLP), a sophisticated model leveraging latent diffusion to predict the progression of neurodegenerative diseases like Alzheimer's by integrating subject-specific metadata and prior knowledge into 3D brain MRI predictions.

Methodology Overview

The BrLP framework encompasses several cutting-edge technologies to enhance its predictive accuracy while efficiently utilizing computational resources:

  1. Latent Space Modeling: BrLP innovatively operates within a reduced latent space, substantially decreasing the computational burden associated with processing 3D imaging data. This approach maintains the integrity of high-dimensional information within a fiscally efficient memory footprint.
  2. Subject Metadata Integration: Through advanced integration techniques, BrLP leverages contextual metadata—such as demographic and clinical characteristics—facilitating personalized predictions. This incorporation addresses the heterogeneity across subjects' disease trajectories.
  3. Longitudinal Data Utilization: By deploying an auxiliary model, BrLP assimilates longitudinal data effectively. This integration allows for a nuanced understanding of disease trajectories as informed by historical volumetric changes within the brain.
  4. Latent Average Stabilization (LAS) Algorithm: The LAS algorithm ensures the temporal consistency of predictions across different time points. This component not only enforces a biologically plausible evolution in predictions but also quantifies prediction uncertainties—enhancing the reliability of BrLP's outcomes.

Experimental Evaluation

The authors conducted extensive evaluations using a dataset comprising 11,730 T1-weighted brain MRIs from 2,805 subjects, assessing BrLP's performance against existing models like 4D-DaniNet and Latent-SADM. The results showcase BrLP's superior accuracy in mirroring real follow-up MRIs, evidenced by quantitative measures. Notably, BrLP demonstrated significant reductions in prediction errors of anatomical structures such as the hippocampus and lateral ventricles, indicative of its enhanced ability to predict disease progression accurately.

Implications and Future Directions

The introduction of BrLP signifies a step forward in individual-level disease progression modeling. By marrying diffusion models with domain-specific knowledge, this framework sets a precedent for future research in medical AI, particularly in harnessing AI to manage and potentially mitigate neurological disorders.

Practically, BrLP offers a promising tool for clinicians and researchers, providing insights that could inform individualized treatment plans and facilitate the early detection of neurodegenerative conditions. The public availability of BrLP's code further amplifies its potential impact, allowing other researchers to expand upon or integrate it into broader diagnostic systems.

Looking forward, future research may explore extending the applicability of BrLP to other progressive diseases and imaging modalities. There is also potential for expanding the model to include additional covariates, such as genetic markers, further honing its predictive accuracy and clinical utility. Moreover, the integration of probabilistic graphical models might offer deeper insights into the nuanced interplay of various biomarkers over time.

In summary, BrLP stands as a robust, versatile model augmenting our toolkit for understanding and predicting the complex trajectories of neurodegenerative diseases. It embodies the convergence of generative modeling and clinical insight, propelling the field towards more personalized and precise medical paradigms.

User Edit Pencil Streamline Icon: https://streamlinehq.com
Authors (3)
  1. Lemuel Puglisi (6 papers)
  2. Daniel C. Alexander (82 papers)
  3. Daniele Ravì (7 papers)
X Twitter Logo Streamline Icon: https://streamlinehq.com